Having long advocated for removal of redundant regulatory burden, Complementary Medicines Australia (CMA) welcomes the Therapeutic Goods Administration’s (TGA) announcement of approval of ten new ingredients that have been assessed as suitable for use in listed medicines.

Read the media release here